EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation
10.1016/j.ccell.2018.06.001 · doi-reference
10.1093/bioinformatics/bty895
10.1093/bioinformatics/bty895 · doi-reference
10.1089/omi.2011.0118
10.1089/omi.2011.0118 · doi-reference
10.1158/1055-9965.epi-18-0243
10.1158/1055-9965.epi-18-0243 · doi-reference
An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis
10.1126/sciadv.abf6063 · doi-reference
10.1182/blood-2009-05-224824
10.1182/blood-2009-05-224824 · doi-reference
10.1016/j.cell.2018.04.012
10.1016/j.cell.2018.04.012 · doi-reference
10.1158/2159-8290.cd-13-0631
10.1158/2159-8290.cd-13-0631 · doi-reference
10.1242/jcs.264187
10.1242/jcs.264187 · doi-reference
10.3389/fcell.2022.927118
10.3389/fcell.2022.927118 · doi-reference
10.1038/nature11083
10.1038/nature11083 · doi-reference
10.1016/j.cell.2012.09.021
10.1016/j.cell.2012.09.021 · doi-reference
10.3389/fmolb.2020.00154
10.3389/fmolb.2020.00154 · doi-reference
Melanoma Metabolism: Molecular Mechanisms and Therapeutic Implications in Cutaneous Oncology
10.1002/cam4.70386 · doi-reference
SLC1A3 contributes to L-asparaginase resistance in solid tumors
10.15252/embj.2019102147 · doi-reference
10.1038/nature13121
10.1038/nature13121 · doi-reference
10.1038/s41556-018-0125-0
10.1038/s41556-018-0125-0 · doi-reference
Primary cilia sense glutamine availability and respond via asparagine synthetase
10.1038/s42255-023-00754-6 · doi-reference
10.1073/pnas.0700776104
10.1073/pnas.0700776104 · doi-reference
Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression
10.1038/jid.2015.22 · doi-reference
TORC1 phosphorylates and inhibits the ribosome preservation factor Stm1 to activate dormant ribosomes
10.15252/embj.2022112344 · doi-reference
Metabolic reprogramming in melanoma therapy
10.1038/s41420-025-02617-3 · doi-reference
10.1038/s41586-022-04758-2
10.1038/s41586-022-04758-2 · doi-reference
Determinants of resistance and response to melanoma therapy
10.1038/s43018-024-00794-1 · doi-reference
10.1056/nejmoa1412690
10.1056/nejmoa1412690 · doi-reference
10.1093/nar/gkv007
10.1093/nar/gkv007 · doi-reference
10.1038/nrm.2017.60
10.1038/nrm.2017.60 · doi-reference
Genome engineering using the CRISPR-Cas9 system
10.1038/nprot.2013.143 · doi-reference
Aspartate in the Brain: A Review
10.1007/s11064-025-04454-3 · doi-reference
10.1158/0008-5472.can-07-5838
10.1158/0008-5472.can-07-5838 · doi-reference
10.1158/2159-8290.cd-13-0440
10.1158/2159-8290.cd-13-0440 · doi-reference
10.1093/nar/gkae253
10.1093/nar/gkae253 · doi-reference
Metabolic Regulation and Energy Homeostasis through the Primary Cilium
10.1016/j.cmet.2014.11.019 · doi-reference
